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Although Poland is officially tuberculosis (TB) free, meaning that less than 
0.1% of her cattle herd is TB-positive, the problem of bovine TB in Poland may be 
re-emerging: its presence has recently been confirmed in domestic and companion 
animals, wildlife such as the European bison, and even humans. The aim of this 
chapter was to review all reports of bovine TB in Poland described to date, with 
particular emphasis on molecular studies, and determine further research direc-
tions. These studies include a range of molecular methods for diagnosis, including 
genotyping, spoligotyping and MIRU- VNTR; such methods successfully identifies 
a tuberculosis-positive European bison as the source of wild boar infection in the 
Bieszczady Mountains based on its spoligotype. This chapter argues that identified 
trains should be better archived, as such records would allow detailed epidemio-
logical investigations and shed greater light on the activity of Mycobacterium spp. 
The current epidemiological situation in Poland highlights the need for further 
studies to determine epidemiological links and confirm possible routes of transmis-
sion based on whole genome sequencing; this need is accentuated by the zoonotic 
potential of such infections and the endangered species at risk.
Keywords: epidemiological investigation, European bison, molecular methods, 
Mycobacterium caprae, Mycobacterium bovis, Poland
1. Introduction
Bovine tuberculosis is a highly-contagious bacterial disease whose etiologi-
cal agents are the acid-fast bovine mycobacteria species Mycobacterium bovis and 
Mycobacterium caprae. These two species can also cause tuberculosis in humans, 
although infection with Mycobacterium tuberculosis is more common. Although 
Poland has been an officially tuberculosis free (OTF) country since 2009, cases are 
still noted in cattle. In addition, M. bovis infection has been observed in emergency 
cases in alpacas and M. caprae has been found in endangered European bison (Bison 
bonasus). Tuberculosis infection has been observed in various other wildlife. The 
aim of this chapter is to present the epizootic situation of bovine tuberculosis in 
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Poland, including its molecular diagnostics, and to determine which molecular 
diagnostic methods would be useful in the future.
2. Tuberculosis in Poland as a zoonosis
Tuberculosis (TB) remains a leading cause of death worldwide. Its treatment 
requires supervision, efficient and reliable diagnostics, contact tracing and effective 
therapy. In 2019, 10 million people with tuberculosis were registered worldwide. 
The incidence of tuberculosis in Poland is slightly higher than the European aver-
age, being 13.9/100.000 in 2019 [1, 2].
Although most cases of human TB are caused by the bacterial species M. tuber-
culosis, this only represents part of a complex that includes various zoonotic forms. 
According to the latest nomenclature, some of the most prominent members of 
this complex known to cause disease in humans or/and animals are M. tuberculosis 
(human), Mycobacterium africanum (human), Mycobacterium canetti (human), 
M. bovis (cattle and other animals), M. caprae (goats, cattle and other animals), 
Mycobacterium pinnipedii (seal), Mycobacterium microti (voles and other small 
rodents) and M. bovis BCG (vaccine strain) [3, 4].
While transmission can take place directly, through the aerogenic route, 
bovine tuberculosis (bTB) is most commonly transmitted to humans though 
an indirect route, possibly through unpasteurized milk or dairy products and 
raw meat. Those at the highest risk of indirect exposure are people exposed to 
the source of infection at work, such as farmers and veterinarians, and those 
working with meat, such as slaughterhouse workers and hunters in contact with 
contaminated animals [5].
According to estimates by the World Health Organization (WHO), in 2016, 
147,000 new cases and 12,500 deaths were associated with zoonotic tuberculosis 
worldwide. However, such figures are often underestimated due to financial 
constraints and the consequent lack of adequate routine control in countries where 
bovine tuberculosis is endemic. Zoonotic tuberculosis tends to be of low prevalence 
where its presence is correctly monitored in animals and appropriate safe food pro-
duction procedures are followed [6, 7]. While over two thirds of human TB cases, 
i.e. those resulting from M. tuberculosis infection, primarily affect the lungs [8], 
zoonotic TB often affects extrapulmonary sites, including lymph nodes and other 
organs [9]. Since bovine mycobacteria causes clinical, radiological and pathologi-
cal symptoms that are similar to M. tuberculosis, these strains can be distinguished 
only by bacterial culture, by biochemical and morphological analysis, and by 
genotyping.
M. bovis used to be differentiated from other complex members based on its 
resistance to pyrazinamide (PZA); however, following the discovery of PZA-
susceptible strains of M. bovis, the species was split into two subspecies: the PZA-
resistant M. bovis subsp. bovis, and the PZA-sensitive M. bovis subsp. caprae [10, 
11]. PZA is one of the four essential drugs used in the current standard first-line 
anti-TB treatment regimen. However, as most healthcare providers initiate treat-
ment without performing any drug susceptibility testing, patients with zoonotic TB 
caused by M. bovis may demonstrate poorer treatment outcomes and may develop 
further resistance to other anti-TB drugs; for example, additional resistance to 
rifampicin and isoniazid has been detected in some M. bovis isolates [12].
Like other bacterial species, the resistance of Mycobacterium tuberculosis complex 
members to antimycobacterial drugs arises from the selection of naturally-resistant 
mutants that are constantly present in every bacterial population. Wild strains 
of mycobacteria belonging to the M. tuberculosis complex that have never been 
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exposed to drugs are naturally sensitive to tuberculostats, with one exception; the 
PZA-resistant M. bovis.
In addition to mutations, mycobacteria can develop phenotypic resistance 
through a change in cell wall permeability, which can impair penetration of the 
drug into the cell, or by employing efflux pumps, which allow the active removal 
of the drug from the cell. Metabolic pathways that bypass “drug-sensitive” sites 
in the cell may also be altered. Regardless of its mechanisms, mycobacterial drug 
resistance always occurs as the result of a selection process, i.e. a change in the ratio 
of drug-sensitive to drug-resistant cells [13, 14].
With the growth of research of the Mycobacterium genome and its drug resis-
tance pathways, the main mechanisms and genes by which mutations cause drug 
resistance have been recognized. Currently, commercial tests based on PCR reac-
tions are used to detect the most common mutations determining the resistance of 
mycobacteria to antibiotics that are crucial in treatment. One such example is the 
line probe assay (LiPA); these employ targeted amplification of specific regions of 
the MTB genome using biotinylated primers followed by reverse hybridization of 
the amplicons to oligo probes immobilized on nitrocellulose strips. Hybridization is 
then detected by a colorimetric reaction. Currently, the most widely used tests are 
those developed by Hain Lifescience (Nehren, Germany): Genotype MTBDRplus 
and Genotype MTBDRsl, detecting resistance to the most important antituberculo-
sis drugs of the I- and II- lines [13].
From the epidemiological and therapeutic point of view, the identification of 
MDR (Multi Drug Resistant), XDR (eXtremely Drug Resistant) and TDR (Totally 
Drug Resistant) MTBC strains is of key importance [15, 16].
Drug-resistant tuberculosis is more difficult to treat than drug-resistant tuber-
culosis. Patients do not recover from the standard six-month treatment regimen, 
but undergo long-term therapy requiring the use of less effective, more toxic and 
more expensive drugs (Table 1) [17].
In Poland and most other developed countries, the threat of bTB in humans 
decreased significantly in the middle of the 20th Century following the introduc-
tion of tuberculosis management strategies [18]. Thanks to the combined imple-
mentation of appropriate eradication and surveillance programs, in 2009, Poland 
was awarded the status of a tuberculosis-free country.
However, in 2020, the first Polish case of bTB in humans was recorded in a 
retrospective study by Kozińska and Augustynowicz-Kopeć [19], which described 
the case of a 46-year-old male detected in 2012 with bacteriologically-confirmed 
pulmonary infection with M. caprae. Changes typical for pulmonary TB were 
Drug Type of 
resistance
Isoniazid + rifampicin MDR
Isoniazid + rifampicin + streptomycin
Isoniazid + rifampicin + ethambutol
Isoniazid + rifampicin + streptomycin + ethambutol
MDR + fluoroquinolone + one of the injectable drugs (amikacin or kanamycin or 
capreomycin)
XDR
INH + RMP + SM + EMB + fluoroquinolone + aminoglycoside + polypeptide + thioamide + 
cycloserine + para-aminosalicylic acid
TDR
Table 1. 
Definitions of drug resistance on MTBC.
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identified on chest X-ray, and a tuberculin test result of 18 mm was obtained. In 
addition, direct staining of sputum revealed the presence of acid-fast mycobacteria 
(AFB ++), and Mycobacterium colonies were identified after four weeks of culture 
on Löwenstein-Jensen (LJ) medium. Initial identification in the hospital labora-
tory confirmed that the isolated strain belonged to the M. tuberculosis complex. 
Phenotypic and molecular methods revealed drug susceptibility, and the strain was 
thus classified to the species M. caprae. Further genotyping identified the unique 
spoligotype 200003757377600; although this strain was not registered in the inter-
national spoligotype databases SpolDB4 and SITVIT WEB, it was found to match 
SB1690 in Mbovis. Org, this being a Spanish isolate from 2009 (Table 2) [20]. The 
source of infection remained unknown: the patient’s history revealed that he had 
not had recent contact with any person with tuberculosis, nor had he been close to 
farm animals which had not been tested for tuberculosis. Until now, this has been 
the only documented case of zoonotic TB in Poland.
As tuberculosis is an infectious disease with a complex epidemiology and 
pathogenesis, it is essential to employ molecular typing (genotyping) methods 
when testing for M. tuberculosis: such tools are fundamental for guiding effective 
epidemiological research, defining the dynamics of transmission, and enabling 
global surveillance of the disease. In addition, genotyping provides an insight into 
the biodiversity and evolution of the pathogen.
Various genotyping methods are used in human and bovine TB research, such 
as IS6110-RFLP (Insertion Sequence 6110-Restriction Fragment Length Polymorphism), 
spoligotyping, MIRU-VNTR (Mycobacterial Interspersed Repetitive Units-Variable 
Number Tandem Repeats), and WGS (Whole Genome Sequencing) [21].
The spoligotyping method takes advantage of a polymorphism within the 
chromosomal region DR (Direct Repeat) found in mycobacteria belonging to the M. 
tuberculosis complex. This region, first described by Hermans in the M. bovis BCG 
P3 strain, is formed by a variable number of direct repeat (DR) sequences, 36 bp 
long, with short (35–41 bp) unique spacer sequences between them [22]. The spacer 
sequences are detected by synthetic oligonucleotide probes complementary to the 
43 known sequenced spacer sequences identified in M. tuberculosis H37Rv and M. 
bovis BCG strains.
Being a PCR-based method, spoligotyping requires very little DNA and thus, 
can be used to detect and identify M. tuberculosis complex bacteria directly in clini-
cal specimens, bypassing the culture step.
Another advantage of spoligotyping is the ease with which typing results can be 
recorded, i.e. in binary and octagonal formats, cataloged, and compared in central 





Culture Growth after four weeks on LJ medium







Characteristics of Mycobacterium caprae – The first human isolate in Poland.
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databases [23] (SpolDB4, SITVIT WEB, Mbovis. Org databases). It is therefore 
commonly employed as a screening method in molecular epidemiological investiga-
tions. It can be used to identify species within the M. tuberculosis complex, provide 
information regarding the lineage of various strains, determine their placement in 
major genetic families and indicate the directions of the global spread of molecular 
families of mycobacteria [24].
However, the detection of tuberculosis transmission foci in closed populations 
of humans and animals, as well as their interspecific transmission, requires the use 
of methods with a higher genome differentiation potential. Therefore, spoligotyp-
ing studies are commonly complemented by the use of MIRU-VNTR analysis and 
WGS [25].
The largest group of VNTR sequences in the Mycobacterium genome are the 
46–100-nucleotide MIRU fragments. Of these 15 to 24 known loci with the highest 
variability were selected for the genetic typing of mycobacteria.
In the MIRU-VNTR method, individual sequences are amplified, and the size 
of the resulting products depends on the number of repeats of the core unit. For 
each locus, the number of repeats of the MIRU or VNTR motif is calculated, which 
allows the results to be cataloged using a 15- or 24-digit MIRU-VNTR code. The 
MIRU-VNTR method is characterized by high sensitivity and repeatability. It allows 
the analyzed strains to be differentiated to a large extent, is relatively easy and is 
distinguished by a short analysis time [26].
Although spoligotyping, MIRU-VNTR and RFLP have a very high diagnostic 
value, they are not suitable for accurately determining the dynamics of TB trans-
mission. The spread of tuberculosis may also occur through short contacts, or in a 
high-risk population where epidemiological links between patients are difficult to 
establish. In addition, as they screen less than 1% of the genome, standard genotyp-
ing techniques therefore have limited discriminatory power and cannot optimally 
detect potential transmission chains.
These limitations can be circumvented by the use of whole genome sequencing 
(WGS). WGS provides comprehensive genetic data as well as information on drug 
resistance, virulence factors, and genome evolution. However, such sequencing 
analysis requires high expenditure, the possession of specialized equipment and 
complex bioinformatic analysis of the results [27].
An accurate confirmation of the molecular relationship of the studied strains, 
supplemented with epidemiological data, can form the basis for identifying the 
transmission of infection between closely-related patients, such as family mem-
bers, as well as among homeless people and immigrant populations, between wild 
animals and livestock, and between humans and animals. Unfortunately, not all 
diagnostic laboratories have the appropriate equipment to perform specialist testing 
based on the analysis of the mycobacterial genome. As a result, current data on the 
transmission of tuberculosis as zoonosis may well be underestimated.
Preventing the development of zoonotic TB in humans requires reducing the 
risk of exposure and transmission at the human-animal interface. However, while 
the principal routes of transmission are known, more information is needed about 
their underlying sociocultural and economic bases, and how to promote safer 
alternatives.
3.  Epizootic situation of bovine tuberculosis in cattle and other animal 
species in Poland, and the molecular characteristics of isolated strains
Bovine tuberculosis is an infectious disease that mainly affects cattle. In 2020, 
seven outbreaks in cattle were recorded in Poland; in the rest of Europe, only France 
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(n = 105) and Germany (n = 10) reported higher numbers of outbreaks, while seven 
outbreaks were noted in Italy and Belgium [28]. Bovine bacilli can cause tuberculo-
sis in other farm species (Figure 1). They show high virulence in natural conditions 
in goats, pigs, sheep and cats [29]; however, the disease is less common in horses 
and dogs [30, 31] Cattle are not very susceptible to human bacilli, but infections 
with M. tuberculosis are known in this species: one case of bovine tuberculosis due 
to M. tuberculosis has been reported in Poland so far [32]. Wild animals living in the 
close vicinity of farms can also be a mycobacterial reservoir. The largest reservoir of 
bovine bacilli in Great Britain is the badger population [33]. However, in Spain, wild 
boar populations represent the largest reservoir of tuberculosis [34]. The transmis-
sion of tuberculosis bacilli occurs in shared pastures, less often as a result of fighting 
or biting.
In Poland, the largest reservoir of bovine bacilli is believed to be sick cattle. 
The spread of infection between herds is usually due to the movement of asymp-
tomatic vector animals. Introducing infected animals into a tuberculosis-free 
herd may cause infection of other animals and disease development in immuno-
compromised animals. However, following the eradication program carried out 
in Poland in 1959–1975, its prevalence has significantly fallen, especially in the 
eastern part of the country. Further progress in the control of the disease in cattle 
herds has been made possible by the application of strict rules and their consistent 
enforcement. As in other European countries, Poland operates a special bovine 
tuberculosis control program, described in detail in the Regulation of the Minister 
of Agriculture and Rural Development and in the amended Instruction of the 
General Veterinary Inspector. These documents require the testing of 1/5 of the 
total cattle population in each county based on bovine and avian purified protein 
derivative (PPD) tuberculin using both single and comparative tuberculin tests. All 
positively reactive animals are eliminated, and all samples from these animals are 
tested in the National Reference Laboratory of Bovine Tuberculosis, located in the 
Figure 1. 
Diagram illustrating transmission of potential tuberculosis cases caused by mycobacteria from the MTBC 
complex.
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Department of Microbiology of the National Veterinary Research Institute (NVRI) 
in Puławy, Poland.
All tissue samples are collected post mortem, prepared and cultured on 
Stonebrinck and Petragnani media, as stipulated by the State Veterinary 
Inspectorate’s Instructions for Laboratory Diagnosis of Bovine Tuberculosis [35]. 
The culture is also supplemented by a biological analysis performed using two 
guinea pigs, and the strain extraction procedure is complemented by GenoType 
MTBC (HAIN Lifescience, Germany) typing kits.
The numbers of outbreaks and sick animals in cattle breeding were found to 
fall during the course of the program, and Poland was recognized as free from 
bovine tuberculosis in 2009. However, a total of 372 outbreaks were recorded in 
cattle herds during the following 10-year period, i.e. in 2009–2019. Almost 1/3 of 
these outbreaks were found in the Masovian Voivodeship, the central region of 
Poland, especially in its northern part [36]. A significant number of outbreaks were 
also recorded in the Greater Poland (Wielkopolskie) (n = 68), Lodzkie (n = 28) 
and Lesser Poland (Malopolskie) voivodeships (n = 24). The smallest number of 
disease outbreaks concerned the Lubusz (Lubuskie) (n = 2) and Opole voivodeships 
(n = 1). Molecular studies to date indicate that 70% of cattle suffering from bovine 
tuberculosis were infected with M. bovis and 30% with M. caprae. In 2010, the 
first case of tuberculosis in a calf caused by M. tuberculosis was confirmed [33]. It 
should be noted, however, that the status of Poland as being officially free of bovine 
tuberculosis was never threatened; on the contrary, compared to other European 
countries, Poland has very favorable data on disease control, particularly consider-
ing that almost six million cattle are farmed there.
Among the M. bovis strains isolated from cattle in Poland, the most common 
individual spoligotype was SB0856, being present in 44% of the tested strains. In 
addition, SB0127 and SB0119 were also frequently observed [37]. Among M. caprae 
strains isolated from cattle, the most common spoligotypes were SB0418, SB2390 
and SB2393 [38].
However, the incidence of bTB is not limited to cattle. In the period of 
2009–2010, cases of bTB were recorded in three zoos in Poland. Of the 12 strains 
isolated from 12 captive animals, viz. six antelopes, three giraffes, two tapirs and 
one alpaca, those from ten animals were identified as M. bovis and two were identi-
fied as M. caprae [37, 39, 40]. Transmission was only confirmed in the antelope herd 
and between tapirs. Unfortunately, it has been suggested that zoos may withhold 
epidemiological data, making it very difficult to conduct epidemiological investiga-
tions and trace the source of infection among rare and valuable animals threatened 
with extinction. During a tuberculosis outbreak in the Slaski Ogród Zooologiczny 
(Silesia Zoo), the decision was made to treat a giraffe with active tuberculosis, with 
unfortunately negative results [41]; this raises the question of whether the research 
team should have undertaken the treatment of an animal with active tuberculosis, 
particularly when considering the potential consequences for public health.
In 2014, a bovine tuberculosis outbreak was also identified among American 
bison (Bison bison) farmed in Poland [42]. In total, three cases of M. caprae strains 
were isolated, all of which were characterized by the spoligo pattern SB1912. Most 
cases of TB among free-living animals and exotic animals kept in zoos in Poland 
are caused by M. caprae strains, with spoligotypes SB1912, SB2391 and SB2392 
predominating [38].
In contrast, sporadic cases of transmission to other species of livestock and 
domestic animals have been reported. For example, one case was found in pigs (Sus 
scrofa f. domestica) kept in the vicinity of a herd in which advanced disease was 
diagnosed [43]. In 2018, bovine tuberculosis was reported among alpacas of British 
origin in Poland [44]. In both cases, the strain was identified as M. bovis spoligotype 
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SB0666, according to the international spoligotype database (www.Mbovis.org); 
this type was first isolated in Great Britain in 2003. bTB has also been confirmed in 
both free-living wild animals and those in breeding centers [45].
Animal strains of MTBC have been analyzed for drug resistance to five basic 
anti-tuberculosis drugs: streptomycin (SM), isoniazid (INH), rifampicin (RMP) 
and ethambutol (EMB), known as SIRE, and PZA. fortunately, the findings indi-
cate that Polish strains of bTB obtained from animals do not show environmental 
resistance [38, 40, 46].
A gap exists in Polish veterinary legislation regarding bovine tuberculosis: so 
far, it makes no explicit mention of M. caprae causing tuberculosis in animals. 
In the Act of 11 March, 2004 on the Protection of Animal Health and Control of 
Infectious Diseases of Animals, Annex 2, bovine tuberculosis is listed as a notifiable 
disease without a disease-causing pathogen. While the disease is mentioned in the 
Regulation of the Minister of Agriculture and Rural Development of 23 November 
2004 on eradication of bovine tuberculosis, it does not indicate an etiological agent. 
Despite the Amendment of the Instruction of the Chief Veterinary Officer No. 
GIWpr-02010/2016 of 8 February 2016, the only pathogenic species listed as caus-
ing bovine tuberculosis is M. bovis.
Poland was declared OTF in 2009 [47], and the fact that the country has 
remained this way for the subsequent 10 years indicates that the procedures used to 
control the disease are effective. Only minor incidents have been reported, and they 
usually occur as a result of incidental errors in anti-epizootic management and the 
carelessness of animal owners. More importantly, such errors do not seem to have 
a decisive impact on the overall bovine tuberculosis situation. Poland currently has 
a consistent policy of eradicating M. bovis/M. caprae infections in cattle herds, and 
the country still meets the formal requirements for a TB-free status.
4.  Bovine tuberculosis in European bison in Poland and the use of 
molecular methods
Even though bTB-positive cattle are considered to constitute the primary 
reservoir of the bovine mycobacterium in Poland, tuberculosis has also been found 
in wildlife such as badgers (Meles meles), wild boar (Sus scrofa), wolves (Canis lupus) 
and European bison (Bison bonasus) [45, 48, 49].
In recent years, of all species diagnosed with bTB in Poland, the European bison 
is the most common [50]. A total of 45 cases of tuberculosis were confirmed in 
European bison in the Bieszczady Mountains during the years 1996–2013 [51]. An 
autopsy identified generalized tuberculosis in a three-year-old female from a free-
living herd in the Brzegi Dolne Forest District. Around the same time, in the years 
1997–2001, 13 out of 18 culled European bison from the same Brzegi Dolne herd 
were microbiologically confirmed to have tuberculosis and the decision was made 
to liquidate the entire herd [49]; however, not all animals were culled, and several 
bison from the herd have still not been found [51].
Other scattered cases have been found in the region. Tuberculosis was con-
firmed in two European bison in the Bieszczady Mountains in 2005–2008 [52]. In 
addition, a positive result in the Górny San herd from Bieszczady in 2009 resulted 
in the entire herd of 24 European bison being culled. Tuberculosis-like lesions 
were found in all individuals, and tuberculosis was microbiologically confirmed 
in 23 [51]. It is possible that the source of infection for the European bison from 
the Brzegi Dolne herd was locally grazed cattle, while the source of infection in the 
Górny San herd may have been individuals that separated from the Brzegi Dolne 
herd. Unfortunately, as no strains from the Brzegi Dolne herd were archived, it 
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was not possible to compare the mycobacteria strains between the two herds; this 
underlines the importance of using molecular methods when studying epidemiol-
ogy among wildlife. Interestingly, a strain isolated from the Górny San was found 
to have the same spoligotype as one isolated from wild boar from the same area, i.e. 
the Bieszczady Mountains [49].
Cases of bTB have been recorded in captive European bison in Poland: in 
Warsaw Zoo, Wolisko and the Smardzewice Bison Breeding Centre. Spoligotyping 
and MIRU-VNTR analysis of the European bison from Smardzewice identified the 
presence of as M. caprae–spoligotype M. bovis _4_ CA 1600 (octagonal pattern: 
200003770003600) (SpolDB4 database) [53]. The source of infection remains 
unknown due to a lack of archived Mycobacteria strains, but there are suspicions 
that it may have been acquired from an individual from Silesia Zoo.
A number of studies have been undertaken recently to address the problems 
associated with the ante mortem diagnosis of tuberculosis in wildlife [54–56]. Such 
studies have also been conducted in European bison [57]. Although a range of 
serology methods have been tried [58], the material for direct detection is collected 
from tracheobronchial lavage, and from swabs and biopsy from retropharyngeal 
lymph nodes. A more recent approach is to combine microbiological testing with 
molecular tests, allowing accurate results to be obtained in a much shorter time. In 
one case, MTBC genetic material was confirmed in laryngeal swab and tracheo-
bronchial lavage using the BD ProbeTec Mycobacterium tuberculosis Complex (DTB) 
Direct Detection Reagent Pack (Becton Dikinson, US) which allows direct detec-
tion of mycobacterial genetic material in a clinical specimen [57]. The test acts by 
amplifying and identifying the target DNA simultaneously. However, the method is 
characterized by inter alia intermittent mycobacterial shedding, which can lead to 
false positive results.
With the current situation of bTB in European bison in Poland in mind, it would 
clearly be advisable to include molecular methods in routine diagnostics, thus 
facilitating more accurate epidemiological investigations and more effective disease 
control.
5.  Tuberculosis in wildlife in Poland, other than European bison, 
including molecular diagnostic methods
Currently, no wildlife tuberculosis monitoring program exists in Poland, except 
when visible lesions suggestive of TB are found in the animal. Despite this, it seems 
that tuberculosis cases are rarely found in wildlife in Poland and are limited to 
the area of the Bieszczady Mountains in Southeast Poland: a region bordered by 
Slovakia and Ukraine, with the highest peak being Tarnica (1346 m a.s.l.). This area 
is characterized by high forest coverage, low human population and low livestock 
abundance [59], unpublished data of the County Veterinary Inspectorate, Ustrzyki 
Dolne, Sanok]. Between 1996 and 2020, most TB cases in this area were found 
in European bison and in wild boar [49, 51, 53, 60–63], and no cases have been 
reported in domestic animals or livestock since 2005. Outside this region, only two 
single cases of TB have been described in wildlife in Poland: the first in a roe deer 
(Capreolus capreolus) near Gdańsk and the second in a European bison in Borecka 
Forest [64, 65].
In the Bieszczady Mountains, the first TB case in wildlife was described in 1996 
in a European bison from the Brzegi Dolne Forest District [52]. Between 1997 and 
2013, TB was recorded in a total of 40 European bison in the region, resulting in 
the culling of two bison herds (Bison bonasus caucasicus) (see section 4) [37, 39, 49, 
52, 60, 66–68]. Since then, no new TB cases have been detected within this species 
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in the Bieszczady region [63]. Even so, over the past 20 years, TB has been found in 
other species of wild animals in the Bieszczady Mountains, mostly in wild boars.
The first case of TB in a wild boar was reported in 2012 in a four-year-old female 
from Nasiczne in the Bieszczady, which was found dead due to Metastrongylus spp. 
invasion. Postmortem examination showed small caseous, yellowish tubercules in 
submandibular lymph nodes, from which M.caprae was isolated (at that time M. 
bovis ssp. caprae). The strain was found to have the same spoligo pattern as those 
strains isolated in 2011 from European bison from the Bieszczady area [45], this 
being 200003777377400, or SB2391 as assigned by www.Mbovis.org [69].
Since then, a number of cases of TB have been found in the Bieszczady wild 
boar population each year. Between 2012 and 2017, M. caprae was isolated from 
the lymph nodes of 21 out of 55 investigated wild boar [63]. These strains were 
subjected to molecular analysis based on spoligotyping according to Kamerbeek 
et al. [70], and MIRU-VNTR typing, as given in the public protocol [71]. A total 
of 15 loci were investigated: MIRU 4, MIRU 10, MIRU 16, MIRU 26, MIRU 31, 
MIRU 40, VNTR 424, VNTR 577, VNTR 2165, VNTR 2401, VNTR 3690, VNTR 
4156, VNTR 2163b, VNTR 1955 and VNTR 4052. All 21 isolated strains shared 
an identical spoligotype 200003777377400 – SB2391. From this group, 19 strains 
shared a single MIRU-VNTR pattern (464652364413423), while the other two 
had patterns that differed with regard to a single locus (464552364413423 and 
463652364413423) [63].
To describe the occurrence of TB in wildlife other than European bison and 
wild boar, both within the Bieszczady Mountain region and elsewhere, lymph node 
samples were collected for analysis from red foxes, wolves, badgers, red deer, roe 
deer and brown bear between 2011 and 2017. M. caprae was isolated from the lymph 
nodes of one roe deer and three wolves. Those animals had no visible TB-like lesions 
[48, 63].
All molecular research of M. caprae strains isolated from wildlife in the 
Bieszczady Mountains has been performed based on hsp65 sequence analysis, the 
GenoType®MTBC (Hain Lifescience, Germany) test, spoligotyping and MIRU-
VNTR analysis. Further studies to determine the epidemiological link and the 
possible route of transmission of the source of infection are needed based on whole 
genome sequencing.
6. Conclusions
In conclusion, bovine tuberculosis remains a real threat in Poland, as indicated 
by the increasing number of cases observed in wildlife and the recent report of the 
first confirmed case of M. caprae infection in human. M. caprae is the main etiologi-
cal agent of bovine tuberculosis in wildlife, and M. bovis in cattle.
We recommend that in Poland, bovine tuberculosis should not only be moni-
tored in cattle but also in wildlife. This is especially true in the European bison 
population, which seems to be highly sensitive to infection. This is highly important 
for protecting public health, maintaining the OTF status of Poland and of course, 
protecting the European bison themselves. In which case, particular attention 
should be paid to the free-living animal population in the Bieszczady Mountains.
There is also a particular need to monitor alpacas, as TB-positive animals pose 
a particular risk to children and disabled people due to increased contact during 
animal therapy.
We recommend the more intensive use of molecular tests in monitoring and the 
proper archiving of the identified DNA. Such molecular methods play an essential 
role in epidemiological investigations, as these can accurately identify the source 
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of infection and effectively control the disease. Their findings also allow steps to be 
taken to reduce the spread of infection. Further studies would be of particular value 
in this regard, particularly those based on whole genome sequencing of archived 
strains of M. bovis and M. caprae from different species in Poland.
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